KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) Gross Margin (2016 - 2025)

Historic Gross Margin for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to 33.7%.

  • Quest Diagnostics' Gross Margin rose 11000.0% to 33.7% in Q3 2025 from the same period last year, while for Sep 2025 it was 33.3%, marking a year-over-year increase of 5700.0%. This contributed to the annual value of 32.86% for FY2024, which is 1400.0% down from last year.
  • According to the latest figures from Q3 2025, Quest Diagnostics' Gross Margin is 33.7%, which was up 11000.0% from 34.15% recorded in Q2 2025.
  • Over the past 5 years, Quest Diagnostics' Gross Margin peaked at 40.22% during Q1 2021, and registered a low of 32.17% during Q4 2023.
  • Its 5-year average for Gross Margin is 34.66%, with a median of 33.7% in 2025.
  • Its Gross Margin has fluctuated over the past 5 years, first skyrocketed by 99200bps in 2021, then crashed by -49000bps in 2022.
  • Over the past 5 years, Quest Diagnostics' Gross Margin (Quarter) stood at 37.39% in 2021, then dropped by -13bps to 32.49% in 2022, then decreased by -1bps to 32.17% in 2023, then grew by 2bps to 32.74% in 2024, then rose by 3bps to 33.7% in 2025.
  • Its Gross Margin was 33.7% in Q3 2025, compared to 34.15% in Q2 2025 and 32.54% in Q1 2025.